Johnson & Johnson CEO Sees Leveling In Elective Procedures, May Boost Sales (JNJ)

Source: feedproxy.google.com

Johnson & Johnson (NYSE:JNJ) CEO William C. Weldon said in an interview that declines in medical spending could be nearing a bottom.The CEO sees...


Read more...